Advances in CrossBoss/Stingray use in antegrade dissection reentry from the Asia Pacific Chronic Total Occlusion Club

Antegrade dissection reentry with Stingray device (Boston Scientific, Marlborough, MA) accounts for 20–34% of the chronic total occlusion (CTO) cases in the various hybrid operators' CTO registries and is an important component of CTO crossing algorithms. The Stingray device can facilitate ante...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Eugene B., Brilakis, Emmanouil S., Lo, Sidney, Kalyanasundaram, Arun, Mashayekhi, Kambis, Kao, Hsien‐Li, Lim, Soo‐Teik, Ge, Lei, Chen, Ji‐Yan, Qian, Jie, Lee, Seung‐Whan, Harding, Scott A., Tsuchikane, Etsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Coronary Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754104/
https://www.ncbi.nlm.nih.gov/pubmed/31769597
http://dx.doi.org/10.1002/ccd.28607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754104/
https://www.ncbi.nlm.nih.gov/pubmed/31769597
http://dx.doi.org/10.1002/ccd.28607

Ejemplares similares